PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2619
https://www.valueinhealthjournal.com/article/S1098-3015(23)05749-2/fulltext
Section Title :
Section Order : 11960
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05749-2&doi=10.1016/j.jval.2023.09.2619
HEOR Topics :
Tags :
Regions :